PREHAB - Improving Condition Before Surgery
Launched by UNIVERSITY HOSPITAL OSTRAVA · Dec 1, 2022
Trial Information
Current as of February 05, 2025
Recruiting
Keywords
ClinConnect Summary
The PREHAB trial is a research study looking at how a prehabilitation program can help patients get healthier before they have surgery for certain types of cancer, specifically esophageal, stomach, and rectal cancer. Prehabilitation is a program designed to improve a person's physical and mental condition before undergoing surgery, which can lead to better outcomes. The study is currently recruiting participants who are between 18 and 74 years old and can have surgery for their cancer. To be eligible, participants need to have a specific type of cancer that can be treated with surgery and should be able to complete certain physical tests.
If you join this trial, you can expect to take part in exercises and activities aimed at improving your health before your surgery. The researchers are looking to see if this program can help patients recover more quickly and feel better overall. It’s important to note that some people may not qualify for the study if they have certain health issues or if their cancer is not operable. If you or a loved one are facing surgery for these types of cancer and are interested in participating, this trial may be a good opportunity to enhance your health before the procedure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • radically operable locally advanced cancer of the esophagus, esophagogastric junction, stomach
- • radically operable locally advanced carcinoma of the rectum
- • the patient is able to handle the planned surgical resection procedure
- • planned preoperative neoadjuvant therapy
- • age \> 18 years
- • the ability to complete a spiroergometric examination
- • the ability to carry out a prehabilitation program consent to participate in the study confirmed by signing the informed consent
- Exclusion Criteria:
- • contraindications for spiroergometric examination
- • limitation on the part of the locomotor system to spiroergometric examination or daily exercise (e.g. amputation, severe gonarthrosis, coxarthrosis)
- • inoperability determined by the interdisciplinary team
- • inability to manage the planned operational performance
- • acute surgical performance
- • synchronous malignant disease
- • multivisceral resection
- • planned non-surgical therapeutic procedure
- • incomplete data
Trial Officials
Irina Chmelová, MD,PhD,MBA
Principal Investigator
University Hospital Ostrava
About University Hospital Ostrava
University Hospital Ostrava is a leading medical research institution located in Ostrava, Czech Republic, dedicated to advancing healthcare through innovative clinical trials and research initiatives. As a prominent sponsor of clinical studies, the hospital combines cutting-edge medical technology with a commitment to patient-centered care, fostering collaborations among multidisciplinary teams of healthcare professionals and researchers. With a focus on ethical standards and regulatory compliance, University Hospital Ostrava aims to contribute to the development of new therapies and improve treatment outcomes across various medical fields. Its robust research infrastructure and dedication to scientific excellence position it as a key player in the advancement of medical knowledge and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ostrava, Moravian Silesian Region, Czechia
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials